Log in to save to my catalogue

Oncolytic viruses: a new class of immunotherapy drugs

Oncolytic viruses: a new class of immunotherapy drugs

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7097180

Oncolytic viruses: a new class of immunotherapy drugs

About this item

Full title

Oncolytic viruses: a new class of immunotherapy drugs

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews. Drug discovery, 2015-09, Vol.14 (9), p.642-662

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Key Points
Oncolytic viruses mediate anti-tumour responses through a dual mechanism involving viral oncolysis of cancer cells and induction of host anti-tumour immunity.
The molecular and cellular mechanisms of action are not fully elucidated but are likely to depend on viral replication within transformed cells, induction of primary cell dea...

Alternative Titles

Full title

Oncolytic viruses: a new class of immunotherapy drugs

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7097180

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7097180

Other Identifiers

ISSN

1474-1776

E-ISSN

1474-1784

DOI

10.1038/nrd4663

How to access this item